Cikkek nyilvánosan hozzáférhető megbízással - Chi-Ping DayTovábbi információ
Valahol hozzáférhető: 44
Identification of essential genes for cancer immunotherapy
SJ Patel, NE Sanjana, RJ Kishton, A Eidizadeh, SK Vodnala, M Cam, ...
Nature 548 (7669), 537-542, 2017
Megbízások: US National Institutes of Health
Preclinical mouse cancer models: a maze of opportunities and challenges
CP Day, G Merlino, T Van Dyke
Cell 163 (1), 39-53, 2015
Megbízások: US National Institutes of Health
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
CN Spencer, JL McQuade, V Gopalakrishnan, JA McCulloch, M Vetizou, ...
Science 374 (6575), 1632-1640, 2021
Megbízások: US National Science Foundation, US Department of Defense, US National …
UVB-induced tumor heterogeneity diminishes immune response in melanoma
Y Wolf, O Bartok, S Patkar, GB Eli, S Cohen, K Litchfield, R Levy, ...
Cell 179 (1), 219-235. e21, 2019
Megbízások: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Epigenetic therapy inhibits metastases by disrupting premetastatic niches
Z Lu, J Zou, S Li, MJ Topper, Y Tao, H Zhang, X Jiao, W Xie, X Kong, ...
Nature 579 (7798), 284-290, 2020
Megbízások: US National Institutes of Health
TGF-β signaling in myeloid cells is required for tumor metastasis
Y Pang, SK Gara, BR Achyut, Z Li, HH Yan, CP Day, JM Weiss, ...
Cancer discovery 3 (8), 936-951, 2013
Megbízások: US National Institutes of Health
Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5−/− mice
Y Li, R Tinoco, L Elmén, I Segota, Y Xian, Y Fujita, A Sahu, R Zarecki, ...
Nature communications 10 (1), 1492, 2019
Megbízások: US National Institutes of Health
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy
E Pérez-Guijarro, HH Yang, RE Araya, R El Meskini, HT Michael, ...
Nature medicine 26 (5), 781-791, 2020
Megbízások: US National Institutes of Health
Genetically engineered mouse models of melanoma
E Pérez‐Guijarro, CP Day, G Merlino, MR Zaidi
Cancer 123 (S11), 2089-2103, 2017
Megbízások: US National Institutes of Health
Strength of immune selection in tumors varies with sex and age
A Castro, RM Pyke, X Zhang, WK Thompson, CP Day, LB Alexandrov, ...
Nature communications 11 (1), 4128, 2020
Megbízások: US National Science Foundation, US National Institutes of Health, Howard …
Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis
KL Marie, A Sassano, HH Yang, AM Michalowski, HT Michael, T Guo, ...
Nature communications 11 (1), 333, 2020
Megbízások: US National Institutes of Health, Howard Hughes Medical Institute
Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma
JS Paradis, M Acosta, R Saddawi-Konefka, A Kishore, S Lubrano, ...
Clinical Cancer Research 27 (11), 3190-3200, 2021
Megbízások: US National Science Foundation, US National Institutes of Health, Canadian …
A direct link between MITF, innate immunity, and hair graying
ML Harris, TD Fufa, JW Palmer, SS Joshi, DM Larson, A Incao, DE Gildea, ...
PLoS biology 16 (5), e2003648, 2018
Megbízások: US National Institutes of Health
Mouse models of UV-induced melanoma: genetics, pathology, and clinical relevance
CP Day, R Marchalik, G Merlino, H Michael
Laboratory investigation 97 (6), 698-705, 2017
Megbízások: US National Institutes of Health, Doris Duke Charitable Foundation
Lentivirus‐mediated bifunctional cell labeling for in vivo melanoma study
CP Day, J Carter, C Bonomi, D Esposito, B Crise, B Ortiz‐Conde, ...
Pigment cell & melanoma research 22 (3), 283-295, 2009
Megbízások: US National Institutes of Health
AT cell resilience model associated with response to immunotherapy in multiple tumor types
Y Zhang, T Vu, DC Palmer, RJ Kishton, L Gong, J Huang, T Nguyen, ...
Nature medicine 28 (7), 1421-1431, 2022
Megbízások: US National Institutes of Health
“Glowing head” mice: a genetic tool enabling reliable preclinical image-based evaluation of cancers in immunocompetent allografts
CP Day, J Carter, ZW Ohler, C Bonomi, R El Meskini, P Martin, ...
PloS one 9 (11), e109956, 2014
Megbízások: US National Institutes of Health
The future of preclinical mouse models in melanoma treatment is now
G Merlino, K Flaherty, NA Pesantes, A Aplin, S Holmen, T Van Dyke, ...
Pigment cell & melanoma research 26 (4), E8, 2013
Megbízások: US National Institutes of Health
A novel PD-L1-targeted shark VNAR single-domain-based CAR-T cell strategy for treating breast cancer and liver cancer
D Li, H English, J Hong, T Liang, G Merlino, CP Day, M Ho
Molecular Therapy-Oncolytics 24, 849-863, 2022
Megbízások: US National Institutes of Health
Concepts in cancer modeling: a brief history
RM Thomas, T Van Dyke, G Merlino, CP Day
Cancer research 76 (20), 5921-5925, 2016
Megbízások: US National Institutes of Health, Howard Hughes Medical Institute, Doris …
A publikációs és a finanszírozási adatokat számítógépes program határozza meg, automatikusan.